KMT2A and leukemia: A very suggestive study identified a novel inhibitor, CCI-006, which targeted mitochondrial respiration and displayed cytotoxicity against MLL-r leukemia cells, while the selective killing phenotype was unsuccessfully replicated using other mitochondrial stressors [8].